Skip to main content
. 2008 Apr 23;2008(2):CD007031. doi: 10.1002/14651858.CD007031

Niphadkar 2005b.

Methods See above.
Participants See above.
Interventions 1. Ciclesonide 200 mcg OD (pm) 
 2. Budesonide 200 mcg BID
See above
Outcomes FEV1; FVC; am PEF; pm PEF; symptoms; rescue medication use; withdrawals; adverse events
Notes Created as secondary reference to Niphadkar 2005 (am) due to additional treatment arm in this trial (pm administration of ciclesonide)
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear